메뉴 건너뛰기




Volumn 69, Issue 11, 2009, Pages 4791-4799

Bacterial cytosine deaminase mutants created by molecular engineering show improved 5-fluorocytosine-mediated cell killing in vitro and in vivo

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; MUTANT PROTEIN;

EID: 66349116702     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-0615     Document Type: Article
Times cited : (41)

References (31)
  • 1
    • 0021880212 scopus 로고
    • Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules
    • Nishiyama T, Kawamura Y, Kawamoto K, et al. Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules. Cancer Res 1985;45:1753-1761
    • (1985) Cancer Res , vol.45 , pp. 1753-1761
    • Nishiyama, T.1    Kawamura, Y.2    Kawamoto, K.3
  • 2
    • 0023518829 scopus 로고
    • Implantable enzyme capsules for cancer chemotherapy from bakers' yeast cytosine deaminase immobilized on epoxy-acrylic resin and urethane prepolymer
    • Katsuragi T, Sakai T, Tonomura K. Implantable enzyme capsules for cancer chemotherapy from bakers' yeast cytosine deaminase immobilized on epoxy-acrylic resin and urethane prepolymer. Appl Biochem Biotechnol 1987;16:61-69
    • (1987) Appl Biochem Biotechnol , vol.16 , pp. 61-69
    • Katsuragi, T.1    Sakai, T.2    Tonomura, K.3
  • 3
    • 0030589523 scopus 로고    scopus 로고
    • Gene-directed enzyme prodrug therapy (GDEPT): Choice of prodrugs
    • Springer CJ, Niculescu-Duvaz I. Gene-directed enzyme prodrug therapy (GDEPT): choice of prodrugs. Adv Drug Deliv Rev 1996;22:351-364
    • (1996) Adv Drug Deliv Rev , vol.22 , pp. 351-364
    • Springer, C.J.1    Niculescu-Duvaz, I.2
  • 4
    • 0027523517 scopus 로고
    • A first step in the development of gene therapy for colorectal carcinoma: Cloning, sequencing, and expression of Escherichia coli cytosine deaminase
    • Austin EA, Huber BE. A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol Pharmacol 1993;43:380-387
    • (1993) Mol Pharmacol , vol.43 , pp. 380-387
    • Austin, E.A.1    Huber, B.E.2
  • 5
    • 0026599586 scopus 로고
    • Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system
    • Mullen CA, Kilstrup M, Blaese RM. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci U S A 1992;89:33-37
    • (1992) Proc Natl Acad Sci U S A , vol.89 , pp. 33-37
    • Mullen, C.A.1    Kilstrup, M.2    Blaese, R.M.3
  • 6
    • 0029995247 scopus 로고    scopus 로고
    • In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine
    • Dong Y, Wen P, Manome Y, et al. In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum Gene Ther 1996;7:713-720
    • (1996) Hum Gene Ther , vol.7 , pp. 713-720
    • Dong, Y.1    Wen, P.2    Manome, Y.3
  • 7
    • 0028108469 scopus 로고
    • Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase
    • Huber BE, Austin EA, Richards CA, Davis ST, Good SS. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci U S A 1994;91:8302-8306
    • (1994) Proc Natl Acad Sci U S A , vol.91 , pp. 8302-8306
    • Huber, B.E.1    Austin, E.A.2    Richards, C.A.3    Davis, S.T.4    Good, S.S.5
  • 8
    • 0028297316 scopus 로고
    • Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor
    • Mullen CA, Coale MM, Lowe R, Blaese RM. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res 1994;54:1503-1506
    • (1994) Cancer Res , vol.54 , pp. 1503-1506
    • Mullen, C.A.1    Coale, M.M.2    Lowe, R.3    Blaese, R.M.4
  • 9
    • 0029943796 scopus 로고    scopus 로고
    • Monitoring gene therapy with cytosine deaminase: In vitro studies using tritiated-5-fluorocytosine
    • Haberkorn U, Oberdorfer F, Gebert J, et al. Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine. J Nucl Med 1996;37:87-94.
    • (1996) J Nucl Med , vol.37 , pp. 87-94
    • Haberkorn, U.1    Oberdorfer, F.2    Gebert, J.3
  • 10
    • 0032526178 scopus 로고    scopus 로고
    • Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-fluorocytosine
    • Lawrence TS, Rehemtulla A, Ng EY, Wilson M, Trosko JE, Stetson PL. Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-fluorocytosine. Cancer Res 1998;58:2588-2593
    • (1998) Cancer Res , vol.58 , pp. 2588-2593
    • Lawrence, T.S.1    Rehemtulla, A.2    Ng, E.Y.3    Wilson, M.4    Trosko, J.E.5    Stetson, P.L.6
  • 11
    • 0027483695 scopus 로고
    • The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified
    • Freeman SM, Abboud CN, Whartenby KA, et al. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993;53:5274-5283
    • (1993) Cancer Res , vol.53 , pp. 5274-5283
    • Freeman, S.M.1    Abboud, C.N.2    Whartenby, K.A.3
  • 12
    • 0022485359 scopus 로고
    • Tumor sensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
    • Moolten FL. Tumor sensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986;46:5276-5281
    • (1986) Cancer Res , vol.46 , pp. 5276-5281
    • Moolten, F.L.1
  • 13
    • 0031788385 scopus 로고    scopus 로고
    • Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil
    • Kuriyama E, Masui K, Sakamoto T, et al. Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil. Anticancer Res 1998;18:3399-3406
    • (1998) Anticancer Res , vol.18 , pp. 3399-3406
    • Kuriyama, E.1    Masui, K.2    Sakamoto, T.3
  • 14
    • 3142668353 scopus 로고    scopus 로고
    • Alanine-scanning mutagenesis reveals a cytosine deaminase mutant with altered substrate preference
    • Mahan SD, Ireton GC, Stoddard BL, Black ME. Alanine-scanning mutagenesis reveals a cytosine deaminase mutant with altered substrate preference. Biochemistry 2004;43:8957-8964
    • (2004) Biochemistry , vol.43 , pp. 8957-8964
    • Mahan, S.D.1    Ireton, G.C.2    Stoddard, B.L.3    Black, M.E.4
  • 15
    • 10844265515 scopus 로고    scopus 로고
    • Random mutagenesis and selection of Escherichia coli cytosine deaminase for cancer gene therapy
    • Mahan SD, Ireton GC, Knoeber C, Stoddard BL, Black ME. Random mutagenesis and selection of Escherichia coli cytosine deaminase for cancer gene therapy. Protein Eng Des Sel 2004;17:625-633
    • (2004) Protein Eng des Sel , vol.17 , pp. 625-633
    • Mahan, S.D.1    Ireton, G.C.2    Knoeber, C.3    Stoddard, B.L.4    Black, M.E.5
  • 17
    • 0043133654 scopus 로고    scopus 로고
    • The 1.14 a crystal structure of yeast cytosine deaminase: Evolution of nucleotide salvage enzymes and implications for genetic chemotherapy
    • Ireton GC, Black ME, Stoddard BL. The 1.14 A crystal structure of yeast cytosine deaminase: evolution of nucleotide salvage enzymes and implications for genetic chemotherapy. Structure 2003;11:961-972
    • (2003) Structure , vol.11 , pp. 961-972
    • Ireton, G.C.1    Black, M.E.2    Stoddard, B.L.3
  • 18
    • 0032029743 scopus 로고    scopus 로고
    • Cloning, overexpression, and purification of cytosine deaminase from Saccharomyces cerevisiae
    • Hayden MS, Linsley PS, Wallace AR, Marquardt H, Kerr DE. Cloning, overexpression, and purification of cytosine deaminase from Saccharomyces cerevisiae . Protein Expr Purif 1998;12:173-184
    • (1998) Protein Expr Purif , vol.12 , pp. 173-184
    • Hayden, M.S.1    Linsley, P.S.2    Wallace, A.R.3    Marquardt, H.4    Kerr, D.E.5
  • 21
    • 0028103275 scopus 로고
    • The CCP4 Suite: Programs for protein crystallography
    • Collaborative Computational Project, Number 4
    • Collaborative Computational Project, Number 4. The CCP4 Suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 1994;50:760-763
    • (1994) Acta Crystallogr D Biol Crystallogr , vol.50 , pp. 760-763
  • 22
    • 0028800141 scopus 로고
    • Enzyme/prodrug gene therapy: Comparison of cytosine deaminase/5- fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line
    • Trinh QT, Austin EA, Murray DM, Knick VC, Huber BE. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Cancer Res 1995;55:4808-4812
    • (1995) Cancer Res , vol.55 , pp. 4808-4812
    • Trinh, Q.T.1    Austin, E.A.2    Murray, D.M.3    Knick, V.C.4    Huber, B.E.5
  • 24
    • 0033119291 scopus 로고    scopus 로고
    • Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts
    • Kievit E, Bershad E, Ng E, et al. Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts. Cancer Res 1999;59:1417-1421
    • (1999) Cancer Res , vol.59 , pp. 1417-1421
    • Kievit, E.1    Bershad, E.2    Ng, E.3
  • 25
    • 0029883624 scopus 로고    scopus 로고
    • Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy
    • Black ME, Newcomb TG, Wilson HM, Loeb LA. Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. Proc Natl Acad Sci U S A 1996;93:3525-3529
    • (1996) Proc Natl Acad Sci U S A , vol.93 , pp. 3525-3529
    • Black, M.E.1    Newcomb, T.G.2    Wilson, H.M.3    Loeb, L.A.4
  • 26
    • 0036708008 scopus 로고    scopus 로고
    • Characterization of herpes simplex virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity
    • Kokoris MS, Black ME. Characterization of herpes simplex virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity. Protein Sci 2002;11:2267-2272
    • (2002) Protein Sci , vol.11 , pp. 2267-2272
    • Kokoris, M.S.1    Black, M.E.2
  • 28
    • 0034547928 scopus 로고    scopus 로고
    • Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts
    • Kievit E, Nyati MK, Ng E, et al. Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts. Cancer Res 2000;60:6649-6655
    • (2000) Cancer Res , vol.60 , pp. 6649-6655
    • Kievit, E.1    Nyati, M.K.2    Ng, E.3
  • 29
    • 0035123128 scopus 로고    scopus 로고
    • Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospective
    • Greco O, Dachs G. Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospective. J Cell Physiol 2001;187:22-36.
    • (2001) J Cell Physiol , vol.187 , pp. 22-36
    • Greco, O.1    Dachs, G.2
  • 30
    • 0030923831 scopus 로고    scopus 로고
    • Gene-directed enzyme prodrug therapy: A review of enzyme/prodrug combinations
    • Niculescu-Duvaz I, Springer CJ. Gene-directed enzyme prodrug therapy: a review of enzyme/prodrug combinations. Expert Opin Investig Drugs 1997;6:685-703.
    • (1997) Expert Opin Investig Drugs , vol.6 , pp. 685-703
    • Niculescu-Duvaz, I.1    Springer, C.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.